Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response.
点击次数：
所属单位：山东大学第二医院
发表刊物：CANCER MANAGEMENT AND RESEARCH
第一作者：贾红英
论文编号：F8DDFA1E37CA496C86A8ED105E39D626
期号：13
字数：4
是否译文：否
发表时间：2021-07-05
发表时间：2021-07-05
上一条： Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine.
下一条： Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta-analysis